GRIFOLS ASIA PACIFIC PTE. LTD.
Overview
GRIFOLS ASIA PACIFIC PTE. LTD. (UEN 198601920M) is a live private company limited by shares in Singapore. It was registered on 10 September 1986 and has operated for 40 years. Its primary (principal) activity is wholesale of medicinal and pharmaceutical products (Western) (SSIC 46461), and its secondary activity is wholesale of basic industrial chemicals (except fertilisers) (SSIC 46641). It has had 2 former names. Since 2024 it has won 1 government contract from 1 public agency. Its registered address is 460 Alexandra Road, #09-01, Mtower, Singapore 119963.
About the business
Grifols Asia Pacific is the Singapore entity of Grifols, a global healthcare company that makes plasma-derived medicines, other biopharmaceuticals and transfusion medicine products.
Profile
Company information
- Legal name
- GRIFOLS ASIA PACIFIC PTE. LTD.
- UEN
- 198601920M
- Status
- Live Company
- Entity type
- Local Company
- Company type
- Private Company Limited by Shares
- Incorporated
- 10 Sep 1986 (40 years ago)
- Annual return
- 2 Jul 2026
- Accounts due
- 31 Jul 2027
- Officers
- 30
Address and contact
- Registered address
- 460 ALEXANDRA ROAD, #09-01, MTOWER, Singapore 119963
- Area
- Pasir Panjang 2, Queenstown (Central Region)
- Postal district
- D05 (Pasir Panjang, Hong Leong Garden, Clementi New Town)
Website and social
- Website
- www.grifols.com (global website)
Business activity
- Primary activity
- 46461 Wholesale of medicinal and pharmaceutical products (Western)
- Secondary activity
- 46641 Wholesale of basic industrial chemicals (except fertilisers)
Name history
- GRIFOLS ASIA PACIFIC PTE. LTD. (current name)
- ALPHA THERAPEUTIC ASIA
- G.C. PHARMACEUTICAL (SINGAPORE)
Government
Contracts
GRIFOLS ASIA PACIFIC PTE. LTD. won 1 government contract from 1 public agency through GeBIZ since April 2020. The total award value is S$13,207,480.
| Tender | Awarded | Amount |
|---|---|---|
| INVITATION TO TENDER FOR THE SUPPLY OF TEST KITS AND LEASE OF AUTOMATED SYSTEMS FOR THE DETECTION OF NUCLEIC ACIDS FOR HEPATITIS B VIRUS, HEPATITIS C VIRUS, HUMAN IMMUNODEFICIENCY VIRUS AND HEPATITIS E VIRUS IN BLOOD DONORSHSA000ETT23000062Health Sciences Authority | 3 Oct 2024 | S$13,207,480 |